logo

Diseases and Drugs

Share

biomarin nov29 Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa on November 24, 2021, Omicron cases have now been reported in at least 15 countries.

fda oct28 It's that time of month again when we take a look back at some of the regulatory news of October and look ahead to what's on the horizon for November.

pfizercovid sep30 The FDA approved 3 novel drugs in the month of September, bringing the total number of novel drug approvals so far this year to 39. Let's take a look at the biotech stocks facing FDA decision in October.

pfizer aug26 As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.

fda july23 27jul21 As July comes to a close, it's time to look back on some of the month's most important news and look forward to what August has in store. In a recent town hall meeting, the US President Joe Biden stated that he expected the FDA to fully approve the COVID-19 vaccines as soon as late August or early September.

fda jun23 As June draws to a close, it's time to take a look back on some of the month's top news stories related to FDA approval and look ahead to what July has in store.

fda may24 So far this month, only 2 *novel drugs have secured regulatory approval in the U.S. - Johnson & Johnson's Rybrevant and Apellis Pharmaceuticals' Empaveli - compared to 6 during the same period last year. Now, let's take a look at the biotech stocks facing FDA decision in June 2021.

fdadecision april28 27mar21 Four novel drugs were approved by the FDA in March taking the tally of new drug approvals in the first quarter of this year to 14. Let's take a look at what's in store for April 2021.

fdaaprovedim sep19 The Food and Drug Administration approved four new drugs last month. In the year 2020, 104 new drugs were approved by the FDA. Now, let us take a look at the new drugs approved by the regulator in January 2021.

fda2021 dec29 As 2020 draws to a close, it's time to take a look back at some of the regulatory news that made headlines in December and look ahead at what's in store for January 2021. As for the novel drug approvals, 53 drugs secured FDA nod in 2020 compared to 48 in 2019. Let's take a look at the biotech companies whose drugs are at the FDA altar awaiting a decision in January 2021.

oxlumo nov37 As November comes to a close, it's time to take a look back at some of the top news stories of the month related to FDA approvals and look ahead at what's in store for December. A couple of firsts happened on the regulatory front in the month. Let's take a look at the biotech stocks that await a ruling from the FDA in December.

Follow RTT